Related Experiment Videos
Pharmacological vs. mechanical reduction in portal pressure: a comparative study
Surgery
|November 1, 1978
Summary
Partial balloon obstruction of the superior mesenteric artery (SMA) effectively reduces portal pressure and flow without the negative systemic effects of vasopressin. This method shows promise for treating portal hypertension.
Area of Science:
- Cardiovascular Physiology
- Gastroenterology
- Surgical Innovation
Background:
- Decreasing superior mesenteric artery (SMA) blood flow can alter splanchnic and systemic hemodynamics.
- Intra-arterial vasopressin and partial balloon obstruction of the SMA are two methods to reduce SMA blood flow.
Purpose of the Study:
- To compare the splanchnic and systemic hemodynamic effects of intra-arterial vasopressin versus partial balloon obstruction of the SMA.
- To evaluate the safety and efficacy of prolonged partial balloon obstruction of the SMA.
Main Methods:
- Six anesthetized dogs underwent both vasopressin infusion and partial balloon obstruction of the SMA to compare hemodynamic changes.
- Five additional dogs had prolonged partial balloon obstruction of the SMA for 5 hours to assess sustained effects and safety.
Main Results:
- Both methods similarly reduced portal pressure, wedge hepatic vein pressure, and portal venous flow.
- Partial balloon obstruction increased cardiac output and heart rate, and decreased systemic vascular resistance, unlike vasopressin which decreased cardiac output and heart rate, and increased systemic vascular resistance.
- Prolonged partial balloon obstruction maintained reduced portal venous pressure and mean arterial pressure without adverse effects or intestinal damage.
Conclusions:
- Partial balloon obstruction of the SMA is as effective as vasopressin in reducing portal pressure and flow.
- Partial balloon obstruction avoids the potentially harmful systemic hemodynamic changes associated with vasopressin infusion.
- Partial balloon obstruction of the SMA presents a potentially advantageous therapeutic option for managing portal venous pressure.